Trial Search Results

Validation of Smartphone App for Head and Neck Cancer Control and Patient Support

The purpose of this study is to evaluate the benefit of a mobile app in patients receiving head and neck radiation. The app will provide supportive educationalinformation to reinforce a prophylactic swallowing exercise program during treatment. The goal of the app is to increase adherence to these exercises thereby leading to an improvement in swallow related outcomes.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Vibrent Health

Collaborator: Massachusetts General Hospital

Stanford Investigator(s):

Intervention(s):

  • Other: Virtual Coach

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Study subjects ≥ 18 years of age.

   - Fluent English speaking subjects.

   - Study subjects capable of providing informed consent.

   - Patients with newly diagnosed non-metastatic head and neck cancer of the oral cavity,
   oropharynx, nasopharynx, hypopharynx, and larynx that require bilateral neck
   radiation. Individuals with unknown primary head and neck cancer with nodal disease
   necessitating bilateral radiation will also be included.

   - Study subjects with a previously untreated head and neck cancer diagnosis requiring a
   definitive course of radiotherapy requiring a prescribed dose of 60Gy or greater.

   - Study subjects who have either an Android or Apple iOS-based smartphone or tablet
   compatible with the Vibrent application.

   - Study subjects who have access to a sufficient monthly data plan (approximately 200
   MB/month), or Internet connection.

Exclusion Criteria:

   - Non-English speaking, or incapable of providing informed consent.

   - Lack of smartphone, tablet, or Internet connection.

   - Inability to use the Vibrent application.

   - Patients being treated for head and neck cancer who do not receive some form of
   primary, adjuvant, or neo-adjuvant radiation therapy will not be considered for the
   study.

   - Patients with recurrent disease.

   - Pregnant women.

   - Individuals under the age of 18.

   - Individuals with contraindications to radiation therapy.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All